The combination of a Cyclin K degrader (e.g., dCeMM2/3/4, PP-C8, or 7f) and DNA-damage agents (e.g., cisplatin, irinotecan, olaparib, or MK-8776) produced synergistic effects in several different types of cancer cells [81,82,83]. Here, CCNK is linked to cancer.